Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pulmonary Disease, Chronic Obstructive 1Pancreatic Neoplasms 1Lung Neoplasms 1Disease 1Diabetes Mellitus, Type 2 1

Interventions

X-Rays 1Tablets 1Sulfonylurea Compounds 1Standard of Care 1Sodium-Glucose Transporter 2 Inhibitors 1Singing 1Pharmacists 1Palliative Care 1Hypnosis 1Hematologic Tests 1General Practitioners 1Exercise 1Dipeptidyl-Peptidase IV Inhibitors 1Cyclosporine 1CIMAvax EGF 1Blood Specimen Collection 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pulmonary Disease, Chronic Obstructive × Sulfonylurea Compounds × 1 year × Clear all
NCT07332156 2026-01-14

Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

Samsung Medical Center

Completed
21,692 enrolled
Thoracic

Diabetes Mellitus, Type 2, Disease, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡